Barely Significant
← all excerpts

Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model.

J Immunother Cancer · 2020 · PMC7689593 · PMID 33239416

1
hedged sentence
0.0710
closest p · 1.4× alpha
0.0710
boldest claim

The sentences

showed a trendp =0.071so close (0.05 < p ≤ 0.1)
However, in terms of long-term survival, the 45-week survival rate was higher in the busulfan group (64.3%, 9/14 humanized mice) than in the irradiation group (20%, 4/20 humanized mice) and Kaplan-Meier survival analysis also showed a trend toward longer survival in busulfan group than radiation group ( figure 2B ; p =0.071).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.